Results 281 to 290 of about 199,652 (389)

Kienbock's disease: Case report and review of the literature. [PDF]

open access: yesRadiol Case Rep
Beyyato S   +10 more
europepmc   +1 more source

The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review

open access: hybrid
Rosanna Campitiello   +10 more
openalex   +1 more source

Gaucher disease, state of the art and perspectives

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Knowledge about Gaucher disease (GD), considered a model for rare diseases, has considerably increased since its discovery. The pathophysiology of this lysosomal disorder is better known, and specific therapies that can control many aspects of the disease have been developed, particularly for the most common form, Type 1 GD.
Fabrice Camou, Marc G. Berger
wiley   +1 more source

Rifampicin-induced thrombocytopenia in a case of progressive systemic sclerosis

open access: gold
Rupali Sachdev   +5 more
openalex   +1 more source

Low‐protein diet for chronic kidney disease: Evidence, controversies, and practical guidelines

open access: yesJournal of Internal Medicine, EarlyView.
Abstract The benefits of a low‐protein diet (LPD) in patients with altered kidney function remain controversial. Dietary intake studies are inherently complex and may present numerous biases that must be understood and controlled. Due to these challenges, the scientific evidence in this area remains limited and is subject to dispute.
Denise Mafra   +4 more
wiley   +1 more source

Hospital‐treated infections and the risk and prognosis of amyotrophic lateral sclerosis: A population‐based study

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Background Infection has been suspected as a risk factor for amyotrophic lateral sclerosis (ALS). However, previous research has focused on specific pathogens and rarely examined the influence of infection on disease progression. Objectives To assess whether hospital‐treated infections correlate with the risk and prognosis of ALS.
Yihan Hu   +8 more
wiley   +1 more source

Tacrolimus (FK506) and therapy of human autoimmune disorders [PDF]

open access: yes, 1996
Abu-Elmagd, K   +8 more
core  

Home - About - Disclaimer - Privacy